Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C‐reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic urothelial cell car...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Brown, Jacqueline T., Liu, Yuan, Shabto, Julie M., Martini, Dylan J., Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren Beth, Joshi, Shreyas S., Kissick, Haydn, Ogan, Kenneth, Harris, Wayne B., Carthon, Bradley C., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2021
Soggetti:
Genitourinary Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100543/
https://ncbi.nlm.nih.gov/pubmed/33634507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13727
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi